A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.
Clinical trial NCT00233870 · COMPLETED
Trial details
- NCT number
- NCT00233870
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2004-06-01
- Primary completion
- 2011-03-01
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.